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Nanotechnologies are one of the main directions 
of modern technological processes in medicine. It is 
predicted, that these technologies would be applied 
in oncology via synthesis of new nanodrugs with their 
target delivery to tumor cells. Methodology of antitu-
mor drug delivery with application of nanotechnologies 
is the one that would allow overcoming some physical 
and pharmacological barriers to elevate the treatment 
efficacy of patients with cancer [1–3].
At present time the search for new technologies 
that on one hand will allow decreasing toxicity of 
drugs via generation and use of special constructions, 
particularly, liposomes, and on the other hand, will 
promote targeted delivery of drugs directly to tumor 
with the use of nanotechnologies, is being actively 
performed. Among constructive approaches to solve 
this task is the development of magnet-operated 
forms of anticancer preparations. This approach con-
sists in general of a complex of cytostatic drugs with 
nano-sized particles of ferri-ferrous oxide that allows 
concentrating anticancer preparation in target area 
under influence of magnetic field.
Presently there are going trials of many nano-sized 
substances that possess ability for targeted delivery 
of anticancer preparations to malignant cells with 
simultaneous decrease of general toxicity [4]. It was 
shown that physico-chemical properties and bio-
logic activity of substances in form of nanoparticles 
often significantly differ from substances in their 
standard physico-chemical state [5]. Particularly, 
metal nanoparticles reveal potent catalytic properties 
exerted in temperature differences up to hundreds 
of degrees, huge magnetic resistance, abnormally 
great magneto-calorimetric effect etc [6]. That’s why 
oncologists pay special attention to possible use of 
nanoferromagnetics.
The first task for determining possible clinical ap-
plication of nanoscale complexes in different branches 
of medicine, particularly in oncology, is study of bio-
logical effects which are able to cause toxic damage in 
cells after their contact with nanoparticles of different 
compositions.
Despite the clinical use of ferromagnetic nanopar-
ticles as magnetic resonance imaging contrast agents 
[7, 8], yet there is insufficiency of experimental 
 studies in vitro [9–11] about toxic effects and biologi-
cal action of ferromagnetics on cells and influence 
of nanosized complexes  containing ferromagnetic 
in liposomal form.
In several studies it was shown that toxic effect 
of nano-sized complexes on cells depends on ma-
terial from which they were composed, their size, 
the  presence of reactive groups on the surface of 
these complexes, their concentration, and cell his-
togenesis [3, 4]. Along with this it was demonstrated 
that the majority of nanosized complexes revealed 
their toxic effect on cells only at high concentrations 
(100–250 g/ml) [12, 13].
The mechanism of penetration of coated and un-
coated nanocomplexes is related to soluble phase of 
endocytosis that has been documented by elevated 
content of protein clarin in cell periphery [14–17] and 
by the data of study that showed that dextran-coated 
nanocomplexes are not receptor-dependent [17].
So, presently there are no final decisions con-
cerning toxic effect and mechanism of biological 
action of stabilized ferromagnetics on malignant 
cells. Also, there is no data about ultrastructural and 
functional changes in tumor cells after the influence 
of ferromagnetics. That’s why we have performed 
a study of ultrastructure and some functional in-
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dexes of tumor cells treated in vitro by stabilized 
iron nanoparticles.
MATERIALS AND METHODS
The objects of our study were wild type, cisplatin-
resistant and doxorubicin-resistant human breast 
cancer cells (MCF-7 cell line) and human ovarian 
cancer cells (А2780 cell line). Original  MCF-7 and 
А2780 cells were cultured in modified Dulbecco IS-
COVE medium (Sigma, Germany) supplemented with 
10% fetal calf serum (“Sangva”, Ukraine) at 37 оС in 5% 
СО2 atmosphere. The cells were passaged twice per 
week at the density of 2–4 x 104 cell/cm2. The resistant 
variants (cisplatin-resistant MCF-7/DDP and А2780/
DDP) and doxorubicin-resistant (MCF-7/Dох, А2780/
Dох) cells were generated by culturing original cells in 
the presence of increasing concentrations of cispla-
tin or doxorubicin. Each two months, cell resistance 
was analyzed by proliferative method with the use of 
3-[4,5dimethylthiazol-2-1]-2,5-diphenyltetrazolium 
bromide (МТТ) method. At the time of experiment, 
the resistance degrees of MCF- 7 cells yielded 4 for 
cisplatin and 8 for doxorubicin, and 5 and 8, respec-
tively , for А2780 cells .
We used magnetite (Fe3O4) synthesized by the 
 method of electron-beam evaporation and Fe3O4 and 
NaCl deposition in vacuum. The stabilization of 
ferromagnetic was carried out by adding polydex-
trane-90 and phosphatidylcholine/cholesterol during 
dispersion. Size of stabilized particles was determined 
using laser correlation spectrometry. Iron concentra-
tions (mg/ml) were measured by atomic-absorption 
spectroscopy [18].
The cells of studied lines were cultured with sta-
bilized ferromagnetic at concentration of 100 g/ml 
for 1, 2 and 3 days. For electron microscopy study, 
the cells were fixed for 1 h in 1.6% glutaraldehyde 
solution prepared in 0.1 М cacodylate buffer (рН 
7.3). To remove glutaraldehyde, the cells were 
washed in 0.1 М cacodylate buffer for 16–18 h. To 
achieve optimal isotonic quality of fixing and wash-
ing buffers, cacodylate buffer was supplemented 
with saccharose (50 mg per ml). Post-fixation of the 
cells was done in 4% osmium tetroxide, with further 
dehydration in alcohols and placement in araldite by 
standard method [19]. Ultrathin slides prepared with 
the use of LKB-8800 ultratome, were contrasted with 
uranyl acetate and plumbous citrate and examined 
using electron microscope  JEM-100B at accelerated 
voltage of 80 kV.
The rate of oxygen uptake by the cells was de-
termined by polarographic method with the use of 
closed Clark’s electrode. In polarographic well, the 
abovementioned medium for cell incubation satu-
rated with oxygen, was placed. The temperature of 
incubation medium was 24 оС. Oxygen uptake rate 
was expressed in nanoatoms of О2/min/1 х 106 cells. 
Statistical analysis of obtained data was performed 
using Student’s t-test.
RESULTS
In our previous studies it was shown that acquire-
ment of resistance to cisplatin and doxorubicin in 
human ovarian cancer cells of А2780 line and human 
breast cancer cells of MCF-7 line is accompanied 
by ultrastructural changes of the cells [20, 21]. For 
drug resistant cells the presence of well developed 
granular endoplasmic reticulum with long channels, 
and 2–3 Golgi apparatus loci was typical. Close to 
Golgi apparatus, a significant quantity of multivesicu-
lar bodies was always present. Resistant cells have a 
nucleus of irregular shape with invaginations and active 
nucleoli located near nuclear membrane that could 
be considered as a pattern of activated metabolism 
in the cells that acquired drug resistance. A lot of 
microtubules, and microfilaments in form of bundles 
of various thickness appeared in resistant cells of 
А2780 and MCF-7 lines.
So, А2780 and MCF-7 cells resistant to doxorubicin 
and cisplatin possess more developed cellular com-
plex connected with elements of cytoskeleton, and 
complicated ultrastructural organization compared 
with wild type cells that evidences a higher degree of 
their differentiation.
After 1 day of incubation with stabilized dispersed 
Fe3O4 in culture medium one could observe the 
 changes of ultrastructural organization in all studied 
cell lines. In cytoplasm phagosomes with ferromag-
netic granules appeared (Fig. 1, а). Some part of 
phagosomes acquired more complex structure being 
united with lysosomes and transformed into phagoly-
sosomes. Only in insignificant part of the cells no fer-
romagnetic was present in cell cytoplasm. The number 
of cells with necrotic patterns was insignificant, and 
was characterized by the presence of a large quantity 
of accumulated granules of ferromagnetic nanopar-
ticles in the content of multiple phagolysosomes. We 
have detected that ferromagnetic nanoparticles were 
localized only in the cytoplasm of studied cells but not 
in cellular organelles. Meanwhile, according to the data 
of literature, TiO2 nanoparticles were accumulated in 
cell mitochondria and nucleus [22].
Ultrastructural organization of wild-type cells in 
contrary to resistant ones was also practically not 
altered. In А2780/S and MCF-7/S cells one could 
observe just an elevation of endoplasmic reticulum 
channels number with a large quantity of ribosomes on 
the outer membrane and elements of Golgi apparatus 
(Fig. 1, b), while in the cells of resistant lines the in-
creased quantity of cell organelles could be detected. 
Altered ultrastructure of all studied lines evidences 
functional loading of this cell organelle in response on 
the presence of Fe3O4 dispersion.
In all studied sublines the changes of cell shape 
detected by light microscopy examination, as well 
as altered ultrastructural organization have been ob-
served. The cells acquired a more round shape with 
the formation of cytoplasm protrusions that promoted 
cell contact perturbation.
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The most damaged organelles seemed to be 
mitochondria that possessed small dimensions with 
electron-dense matrix. These alterations of mito-
chondrial structure indicate a significant functional 
failure of these organelles and have been supported 
by the data of experiments on the rate of oxygen 
uptake by mitochondria. Altered structure of mito-
chondria may be caused by release of free radicals 
by iron present in nanoparticles that leads to inhibition 
of functional  activity of mitochondria and some other 
cell organelles [23].
One of the characteristic features of resistant 
sublines was the presence of significantly larger 
numbers of phagosomes that were composed from 
conglomerates of electron-dense ferromagnetic 
granules of various forms and in different quantity 
(Fig. 1, с). It could be related to quicker accumula-
tion of ferromagnetic in resistant cells compared with 
sensitive ones or with the functional state of resistant 
cells that possess more complex structural organiza-
tion with the presence of significantly higher quantity 
of cell organelles that leads to rapid formation of 
complex phagolysosomes.
Intact resistant cells of А2780 and MCF-7 sublines 
are characterized by the presence of large numbers of 
microtubules, microfilaments, that form the bundles 
of different thickness localized near nucleus invagi-
nations in A2780/Dox cells, or plasma membrane in 
А2780/DDP cells. So, drug resistant cells possess well 
developed cell complex associated with elements of 
cytoskeleton. However, after action of ferromagnetic 
cytoskeleton structural regularity became disturbed 
or the components of cytoskeleton underwent de-
orientation which is illustrated by the presence of 
only few small bundles of microfilaments localized in 
cytoplasm of studied cells (Fig. 1, d). It could be re-
lated to an appearance of phagolysosomes which, as 
it is known, move in cells along microtubules with the 
help of microfilaments and fibrilla. Phagosomes are 
bound to cytoskeleton filaments with the use of motor 
proteins (like myosin, kinesin, or di nein), which leads 
to ATP release and promotes transfer of phagolyso-
somes containing ferromagnetic, inside the cells [24]. 
Possibly, exactly the presence of large quantity of pha-
golysosomes leads to re-distribution of cytoskeleton 
elements that is required for cell functioning in altered 
conditions. Apart from this, ferromagnetic may cause 
alterations in cytoskeleton structure and function via 
direct influence on the structure of proteins that form 
cytoskeleton or indirectly affect cell functional state. 
Altered cell shape upon ferromagnetic action could 
also be caused by the reconstruction and the changed 
orientation of main elements and proteins of cytoskel-
eton, first of all, actin that is the main component of 
cell cytoskeleton and is responsible for cell shape, 
migration and distribution [25].
Ultrastructural study of cells treated with ferro-
magnetic for 2 days allowed to detect its elevated 
accumulation in the cells of all studied lines (Fig. 
2, a). Ultrastructural patterns of cells were practically 
unaltered except for the formation of much higher 
numbers of phagolysosomes of larger size. It’s nec-
essary to note that in the cells of studied sublines 
further increase of apical part of cytoplasm could be 
a
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Fig. 1. Ultrastructure of tumor cells after 1 day of exposure to stabilized Fe3O4 dispersion: a, — sensitive to antitumor drugs A2780 hu-
man ovarian cancer cells, X10000; b, — sensitive to antitumor drugs MCF-7 human breast cancer cells, X10000; c, — resistant 
to doxorubicin A2780/Dox human ovarian cancer cells, X10000; d, — presence of single microfilament bunches in cytoplasm of 
sensitive MCF-7 human breast cancer cells, X20000
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observed, which could be explained by larger total 
volume of nanoparticles accumulated by the cells. The 
structure of mitochondria remained altered especially 
in MCF-7/Dox cells (Fig.  2, b).
After 3 days of incubation of cells with ferromagnetic 
dispersion, a gradual decrease of its accumulation in 
the cells of all studied sublines has been detected 
(Fig. 3, a). Ferromagnetic has been removed from the 
cells by exocytosis of phagolysosomes in intercellu-
lar space, as well as by clasmacytosis (separation of 
small parts of cytoplasm containing large quantities of 
ferromagnetic) (see Fig. 2, b). At the third day of incu-
bation all studied sublines showed significant number 
of blebs of various sizes with different quantity of 
ferromagnetic located on cell membrane.  The  number 
of blebs elevated along with the increase of incubation 
period with nanoparticles.
a
b
Fig. 2. Ultrastructure of tumor cells after 2 days of exposure to 
stabilized Fe3O4 dispersion: a, — resistant to doxorubicin human 
ovarian cancer A2780 cells, X10000; b, — resistant to doxorubi-
cin human breast cancer MCF-7 cells, X10000
Among mechanisms of toxic action of small sized 
nanoparticles one should mention their ability to 
damage mitochondria that are indicators of cell func-
tional state most sensitive to the action of damaging 
factors. It is known that among early signs of cell 
damage there are alterations of mitochondrial ultra-
structure determined as formation of electron-dense 
mitochondria with weakly contoured crists, and their 
vacuolization. Exactly such structure of mitochondria 
was observed by us in the cells treated with nanocom-
plexes (Fig. 3, c).
After 8 days of cultivation of MCF-7 cells in stan-
dard medium that replaced ferromagnetic after 3-days 
incubation, such altered ultrastructure of mitochondria 
still could be observed in some cases.
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Fig. 3. Ultrastructure of tumor cells after 3 days of exposure to 
stabilized Fe3O4 dispersion: a, — resistant to doxorubicin human 
ovarian cancer A2780 cells, X10000; b, — sensitive to antitumor 
drugs A2780 human ovarian cancer cells, X10000; c, — severe 
damage of mitochondria structure in resistant to doxorubicin 
human ovarian cancer A2780 cells, X15000
It is known that 90–97% of oxygen in cells is me-
tabolized by mitochondria [26]. Taking into account 
that many complexes of mitochondrial respiratory 
chain contain iron [27], we have studied an influence 
of stabilized nanoferromagnetic on the rate of oxygen 
uptake by MCF-7/S, MCF-7/ DDP and MCF-7/Dox 
cells. It has been revealed that intact MCF-7/Dox cells 
uptake oxygen somewhat more rapidly than original 
MCF-7/S cells (0.05 < p < 0.1; Table). This fact is in 
accordance with our earlier data obtained on rat tumor 
cells [28]. Interestingly enough, 48 h incubation with 
ferromagnetic resulted in decreased rate of oxygen 
uptake by the cells, but at different degree in differ-
ent cell sublines (see Table). After incubation with 
ferromagnetic the rate of oxygen uptake by MCF-7/S 
cells significantly decreased (by 33%; p < 0.05), while 
in MCF-7/DDP and MCF-7/Dox cells it decreased by 
10 and 21%, respectively. This fact evidenced the re-
Experimental Oncology 32, 237–242, 2010 (December) 241
sistance of MCF-7/DDP and MCF-7/Dox cells not only 
to some cytostatics, but also to some other agents, 
for example, to ferromagnetics of certain composition 
and size. These data are important for further studies 
of effective antitumor nanocomposites designed for 
use in vivo.
Table. Oxygen uptake rate in MCF-7/S, MCF-7/ DDP and MCF-7/Dox 
cells after their incubation for 48 h with ferromagnetic stabilized with dex-
tran and phosphatidylcholine (n = 5). Oxygen uptake rate was expressed in 
nanoatoms of О2/min/1 х 106 cells
Treatment Cell lineMCF-7/S MCF-7/DDP MCF-7/Dox
Сontrol 10.8 ± 0.2 10.3 ± 0.7 12.2 ± 1.0
After 48 h incubation with ferro-
magnetic
7.2 ± 0.4* 9.3 ± 1.2 9.6 ± 0.7
Note: *difference is significant compared with respective control (p < 0.05).
In conclusion, it has been shown in our study that 
cultivation of cells with stabilized Fe3O4 dispersion 
leads to intracellular accumulation of ferromagnetic 
nanoparticles. The most active ferromagnetic uptake 
by wild type cells have been observed after 24 h 
and 48 h of incubation. Resistant cells accumulated 
iron more slowly and its maximal concentration was 
registered after 48 h. The presence of ferromagnetic 
in culture medium has led to altered mitochondrial 
structure which caused the decrease of oxygen up-
take rate. Also, the decrease of the oxygen uptake 
rate by the cells that may also promote cytotoxic 
damage upon treatment with stabilized iron occured. 
In the large majority of cells after 72 h of incubation 
ferromagnetic was released from nanoparticles via 
exocytosis or clasmacytosis. One could detect such 
ferromagnetic particles in intercellular space. After 
72 h in significant number of cells no ferromagnetic 
particles could be observed. The number of dead cells 
or cells with severe damage was moderate enough, 
so cytotoxic action of nanoparticles of stabilized iron 
toward studied cell lines was minimal. The results of 
our study allow us to conclude that the presence of 
ferromagnetic in culture medium leads to alteration 
of ultrastructural organization and decreased oxygen 
uptake by mitochondria in the cells sensitive and re-
sistant to anticancer drugs.
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